RA Capital Nexus Fund II, L.P., 10% Owner at AN2 Therapeutics, Inc. (ANTX), bought 46,438 shares at $7.91 ($361K) on 2022-07-27, disclosed to the SEC on 2022-07-28.
Open-market purchase of $361k ANTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.71 | 14,938 | $115K | 31.9% |
| 2 | $7.71 | 14,938 | $115K | 31.9% |
| 3 | $7.91 | 8,281 | $66K | 18.1% |
| 4 | $7.91 | 8,281 | $66K | 18.1% |
| Total | $7.78 avg | 46,438 | $361K | 100% |
| Filing → |
| ANTX | BUY | 2023-08-22 | $16.0M | — | Filing → |
| JANX | BUY | 2023-07-21 | $12.3M | — | Filing → |
| DICE | BUY | 2023-03-30 | $29.6M | — | Filing → |